Mon, May 12, 2014
Fri, May 9, 2014
Thu, May 8, 2014
Wed, May 7, 2014
Tue, May 6, 2014
Mon, May 5, 2014
Fri, May 2, 2014
Thu, May 1, 2014
Wed, April 30, 2014
Tue, April 29, 2014
Mon, April 28, 2014
Fri, April 25, 2014
Thu, April 24, 2014
Wed, April 23, 2014
Tue, April 22, 2014
Mon, April 21, 2014
Thu, April 17, 2014
Wed, April 16, 2014
Tue, April 15, 2014
Mon, April 14, 2014
Fri, April 11, 2014
Thu, April 10, 2014
Wed, April 9, 2014
Tue, April 8, 2014
Mon, April 7, 2014
Fri, April 4, 2014
Thu, April 3, 2014
Wed, April 2, 2014

Christopher Marai Maintained (BIIB) at Strong Buy with Increased Target to $415 on, Apr 24th, 2014

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-415-on-apr-24th-2014.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Marai of Nomura, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $413 to $415 on, Apr 24th, 2014.

Christopher has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $415 on, Tuesday, January 28th, 2014